Katarzyna Bogucka-Janczi (Katarzyna Bogucka)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Ejection Fraction

Top Venues

Cancer gene therapy

University Medical Center of the Johannes Gutenberg University Mainz

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Medical Center of the Johannes Gutenberg University Mainz

Germany

PostDoc :: Cell Biology Unit

Publications

Katarzyna Bogucka-Janczi, Gregory Harms, Marie-May Coissieux, Mohamed Bentires-Alj, Bernd Thiede, Krishnaraj Rajalingam
ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization. eLife 12 (2023)
Katarzyna Bogucka-Janczi, Federico Marini, Sebastian Rosigkeit, Janine Schloeder, Helmut Jonuleit, Kerstin David, Margarita Schlackow, Krishnaraj Rajalingam
ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis. Cancer gene therapy 28 (5) (2020)
Katarzyna Bogucka-Janczi, Federico Marini, Sebastian Rosigkeit, Janine Schloeder, Helmut Jonuleit, Kerstin David, Margarita Schlackow, Krishnaraj Rajalingam
Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis. Cancer gene therapy (2020)